Serotonin Regulates Lipogenesis and Endoplasmic Reticulum Stress in Alcoholic Liver Disease
Background: Serotonin (5-hydroxytryptamine [5-HT]) is a monoamine neurotransmitter that has various functions in central and peripheral tissues. While 5-HT is known to regulate various biological processes in liver, direct role of 5-HT and its receptors, especially 5-HT receptor 2A (HTR2A) and HTR2B...
Saved in:
Published in | Diabetes & metabolism journal Vol. 49; no. 4; pp. 798 - 811 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
Korean Diabetes Association
01.07.2025
대한당뇨병학회 |
Subjects | |
Online Access | Get full text |
ISSN | 2233-6079 2233-6087 2233-6087 |
DOI | 10.4093/dmj.2024.0215 |
Cover
Abstract | Background: Serotonin (5-hydroxytryptamine [5-HT]) is a monoamine neurotransmitter that has various functions in central and peripheral tissues. While 5-HT is known to regulate various biological processes in liver, direct role of 5-HT and its receptors, especially 5-HT receptor 2A (HTR2A) and HTR2B, in development and progression of alcoholic liver disease (ALD) in vivo is not well understood.Methods: Blood 5-HT level was measured from both human ALD patients and ethanol (EtOH) diet-fed mouse models. Gut-specific tryptophan hydroxylase 1 (Tph1) knockout mice, liver-specific Htr2a knockout mice, and liver-specific Htr2b knockout mice were fed with EtOH diet. Then we evaluated liver damage, hepatic steatosis, endoplasmic reticulum (ER) stress, and inflammation.Results: Blood 5-HT concentrations are increased in both humans and mice with ALD. Both gut-specific Tph1 knockout and liver- specific Htr2a knockout mice are resistant to steatosis by down-regulating lipogenic pathways in liver of chronic EtOH diet-fed mice. Moreover, genetic inhibition of both gut-derived serotonin (GDS) synthesis and hepatic HTR2A signaling prevents ER stress in liver of chronic EtOH diet-fed mice. Additionally, we found that ablation of HTR2A signaling protects against disease progression by attenuating liver injury and inflammation in chronic plus binge EtOH diet-fed mice. Also, inhibiting HTR2A signaling ameliorates alcohol-induced liver injury and ER stress in an acute EtOH diet-fed mice model.Conclusion: GDS directly regulates lipogenesis and ER stress via signaling through hepatic HTR2A in the context of ALD. Inhibiting HTR2A signaling protects against alcohol-induced steatosis, liver injury and disease progression in various ALD mouse models and may also provide a novel therapeutic strategy for ALD. |
---|---|
AbstractList | Background Serotonin (5-hydroxytryptamine [5-HT]) is a monoamine neurotransmitter that has various functions in central and peripheral tissues. While 5-HT is known to regulate various biological processes in liver, direct role of 5-HT and its receptors, especially 5-HT receptor 2A (HTR2A) and HTR2B, in development and progression of alcoholic liver disease (ALD) in vivo is not well understood. Methods Blood 5-HT level was measured from both human ALD patients and ethanol (EtOH) diet-fed mouse models. Gut-specific tryptophan hydroxylase 1 (Tph1) knockout mice, liver-specific Htr2a knockout mice, and liver-specific Htr2b knockout mice were fed with EtOH diet. Then we evaluated liver damage, hepatic steatosis, endoplasmic reticulum (ER) stress, and inflammation. Results Blood 5-HT concentrations are increased in both humans and mice with ALD. Both gut-specific Tph1 knockout and liver-specific Htr2a knockout mice are resistant to steatosis by down-regulating lipogenic pathways in liver of chronic EtOH diet-fed mice. Moreover, genetic inhibition of both gut-derived serotonin (GDS) synthesis and hepatic HTR2A signaling prevents ER stress in liver of chronic EtOH diet-fed mice. Additionally, we found that ablation of HTR2A signaling protects against disease progression by attenuating liver injury and inflammation in chronic plus binge EtOH diet-fed mice. Also, inhibiting HTR2A signaling ameliorates alcohol-induced liver injury and ER stress in an acute EtOH diet-fed mice model. Conclusion GDS directly regulates lipogenesis and ER stress via signaling through hepatic HTR2A in the context of ALD. Inhibiting HTR2A signaling protects against alcohol-induced steatosis, liver injury and disease progression in various ALD mouse models and may also provide a novel therapeutic strategy for ALD. Serotonin (5-hydroxytryptamine [5-HT]) is a monoamine neurotransmitter that has various functions in central and peripheral tissues. While 5-HT is known to regulate various biological processes in liver, direct role of 5-HT and its receptors, especially 5-HT receptor 2A (HTR2A) and HTR2B, in development and progression of alcoholic liver disease (ALD) in vivo is not well understood.BackgroundSerotonin (5-hydroxytryptamine [5-HT]) is a monoamine neurotransmitter that has various functions in central and peripheral tissues. While 5-HT is known to regulate various biological processes in liver, direct role of 5-HT and its receptors, especially 5-HT receptor 2A (HTR2A) and HTR2B, in development and progression of alcoholic liver disease (ALD) in vivo is not well understood.Blood 5-HT level was measured from both human ALD patients and ethanol (EtOH) diet-fed mouse models. Gut-specific tryptophan hydroxylase 1 (Tph1) knockout mice, liver-specific Htr2a knockout mice, and liver-specific Htr2b knockout mice were fed with EtOH diet. Then we evaluated liver damage, hepatic steatosis, endoplasmic reticulum (ER) stress, and inflammation.MethodsBlood 5-HT level was measured from both human ALD patients and ethanol (EtOH) diet-fed mouse models. Gut-specific tryptophan hydroxylase 1 (Tph1) knockout mice, liver-specific Htr2a knockout mice, and liver-specific Htr2b knockout mice were fed with EtOH diet. Then we evaluated liver damage, hepatic steatosis, endoplasmic reticulum (ER) stress, and inflammation.Blood 5-HT concentrations are increased in both humans and mice with ALD. Both gut-specific Tph1 knockout and liver- specific Htr2a knockout mice are resistant to steatosis by down-regulating lipogenic pathways in liver of chronic EtOH diet-fed mice. Moreover, genetic inhibition of both gut-derived serotonin (GDS) synthesis and hepatic HTR2A signaling prevents ER stress in liver of chronic EtOH diet-fed mice. Additionally, we found that ablation of HTR2A signaling protects against disease progression by attenuating liver injury and inflammation in chronic plus binge EtOH diet-fed mice. Also, inhibiting HTR2A signaling ameliorates alcohol-induced liver injury and ER stress in an acute EtOH diet-fed mice model.ResultsBlood 5-HT concentrations are increased in both humans and mice with ALD. Both gut-specific Tph1 knockout and liver- specific Htr2a knockout mice are resistant to steatosis by down-regulating lipogenic pathways in liver of chronic EtOH diet-fed mice. Moreover, genetic inhibition of both gut-derived serotonin (GDS) synthesis and hepatic HTR2A signaling prevents ER stress in liver of chronic EtOH diet-fed mice. Additionally, we found that ablation of HTR2A signaling protects against disease progression by attenuating liver injury and inflammation in chronic plus binge EtOH diet-fed mice. Also, inhibiting HTR2A signaling ameliorates alcohol-induced liver injury and ER stress in an acute EtOH diet-fed mice model.GDS directly regulates lipogenesis and ER stress via signaling through hepatic HTR2A in the context of ALD. Inhibiting HTR2A signaling protects against alcohol-induced steatosis, liver injury and disease progression in various ALD mouse models and may also provide a novel therapeutic strategy for ALD.ConclusionGDS directly regulates lipogenesis and ER stress via signaling through hepatic HTR2A in the context of ALD. Inhibiting HTR2A signaling protects against alcohol-induced steatosis, liver injury and disease progression in various ALD mouse models and may also provide a novel therapeutic strategy for ALD. Background: Serotonin (5-hydroxytryptamine [5-HT]) is a monoamine neurotransmitter that has various functions in central and peripheral tissues. While 5-HT is known to regulate various biological processes in liver, direct role of 5-HT and its receptors, especially 5-HT receptor 2A (HTR2A) and HTR2B, in development and progression of alcoholic liver disease (ALD) in vivo is not well understood.Methods: Blood 5-HT level was measured from both human ALD patients and ethanol (EtOH) diet-fed mouse models. Gut-specific tryptophan hydroxylase 1 (Tph1) knockout mice, liver-specific Htr2a knockout mice, and liver-specific Htr2b knockout mice were fed with EtOH diet. Then we evaluated liver damage, hepatic steatosis, endoplasmic reticulum (ER) stress, and inflammation.Results: Blood 5-HT concentrations are increased in both humans and mice with ALD. Both gut-specific Tph1 knockout and liver- specific Htr2a knockout mice are resistant to steatosis by down-regulating lipogenic pathways in liver of chronic EtOH diet-fed mice. Moreover, genetic inhibition of both gut-derived serotonin (GDS) synthesis and hepatic HTR2A signaling prevents ER stress in liver of chronic EtOH diet-fed mice. Additionally, we found that ablation of HTR2A signaling protects against disease progression by attenuating liver injury and inflammation in chronic plus binge EtOH diet-fed mice. Also, inhibiting HTR2A signaling ameliorates alcohol-induced liver injury and ER stress in an acute EtOH diet-fed mice model.Conclusion: GDS directly regulates lipogenesis and ER stress via signaling through hepatic HTR2A in the context of ALD. Inhibiting HTR2A signaling protects against alcohol-induced steatosis, liver injury and disease progression in various ALD mouse models and may also provide a novel therapeutic strategy for ALD. KCI Citation Count: 0 Serotonin (5-hydroxytryptamine [5-HT]) is a monoamine neurotransmitter that has various functions in central and peripheral tissues. While 5-HT is known to regulate various biological processes in liver, direct role of 5-HT and its receptors, especially 5-HT receptor 2A (HTR2A) and HTR2B, in development and progression of alcoholic liver disease (ALD) in vivo is not well understood. Blood 5-HT level was measured from both human ALD patients and ethanol (EtOH) diet-fed mouse models. Gut-specific tryptophan hydroxylase 1 (Tph1) knockout mice, liver-specific Htr2a knockout mice, and liver-specific Htr2b knockout mice were fed with EtOH diet. Then we evaluated liver damage, hepatic steatosis, endoplasmic reticulum (ER) stress, and inflammation. Blood 5-HT concentrations are increased in both humans and mice with ALD. Both gut-specific Tph1 knockout and liver- specific Htr2a knockout mice are resistant to steatosis by down-regulating lipogenic pathways in liver of chronic EtOH diet-fed mice. Moreover, genetic inhibition of both gut-derived serotonin (GDS) synthesis and hepatic HTR2A signaling prevents ER stress in liver of chronic EtOH diet-fed mice. Additionally, we found that ablation of HTR2A signaling protects against disease progression by attenuating liver injury and inflammation in chronic plus binge EtOH diet-fed mice. Also, inhibiting HTR2A signaling ameliorates alcohol-induced liver injury and ER stress in an acute EtOH diet-fed mice model. GDS directly regulates lipogenesis and ER stress via signaling through hepatic HTR2A in the context of ALD. Inhibiting HTR2A signaling protects against alcohol-induced steatosis, liver injury and disease progression in various ALD mouse models and may also provide a novel therapeutic strategy for ALD. |
Author | Kim, Hail Choi, Wonsuk Hwang, Inseon Nam, Jung Eun Lee, Eunji Kim, Hyeongseok Park, Jun Yong Choi, Won Gun Moon, Young-Ah |
Author_xml | – sequence: 1 givenname: Inseon orcidid: 0009-0006-5191-4525 surname: Hwang fullname: Hwang, Inseon – sequence: 2 givenname: Jung Eun orcidid: 0000-0002-7021-8406 surname: Nam fullname: Nam, Jung Eun – sequence: 3 givenname: Wonsuk surname: Choi fullname: Choi, Wonsuk – sequence: 4 givenname: Won Gun surname: Choi fullname: Choi, Won Gun – sequence: 5 givenname: Eunji surname: Lee fullname: Lee, Eunji – sequence: 6 givenname: Hyeongseok surname: Kim fullname: Kim, Hyeongseok – sequence: 7 givenname: Young-Ah surname: Moon fullname: Moon, Young-Ah – sequence: 8 givenname: Jun Yong orcidid: 0000-0001-6324-2224 surname: Park fullname: Park, Jun Yong – sequence: 9 givenname: Hail orcidid: 0000-0002-6652-1349 surname: Kim fullname: Kim, Hail |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39905656$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003222188$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNpVkk1rGzEQhkVJaT6aY69lj6VgV99anYpJ0tRgKCTpqQehlbSOHK3kSruB_vvKdmoaXUbMPPOOxLzn4CSm6AD4gOCcQkm-2GEzxxDTOcSIvQFnGBMy47AVJ8e7kKfgspQNrIe2UAj5DpwSKSHjjJ-BX_cupzFFH5s7t56CHl1pVn6b1i664kujo21uok3boMvgTaVGb6YwDc39mF0pTe1cBJMeU6jVlX92ubn2xeni3oO3vQ7FXb7EC_Dz283D1ffZ6sft8mqxmhnCMZu1naailbTtCCOGCEGR6YyUfc-YMZYYqHVHuEGaWEOolJoirplwvKVM9ppcgM8H3Zh79WS8Strv4zqpp6wWdw9LhaAgmBFR4eUBtklv1Db7Qec_-459IuW10rl-MThlieSitcj2oo6UuLXW8g4i2UnuqGBV6-tBazt1g7PGxTHr8Er0dSX6x_qoZ4UwFnUBsip8elHI6ffkyqgGX4wLQUeXpqII4oTt9gYr-vH_Yccp_3ZZgdkBMDmVkl1_RBBUO7uoahe1s4va2YX8BZ8Wsf0 |
Cites_doi | 10.1111/j.1365-2982.2009.01370.x 10.1016/s0140-6736(09)60746-7 10.1016/s0016-5085(03)00276-2 10.1038/s41598-018-36097-6 10.1002/hep.26419 10.1111/j.1440-1746.2007.05276.x 10.1155/2012/479348 10.1016/j.tips.2018.03.004 10.1385/mn:29:1:31 10.1002/hep.23258 10.1155/2014/513787 10.1016/j.jhep.2013.03.007 10.1038/nprot.2013.032 10.1038/nm1780 10.1111/j.1463-1326.2011.01378.x 10.1126/science.1123842 10.1097/01.alc.0000174691.03751.11 10.1126/science.1097540 10.1038/nm.2490 10.1016/j.cmet.2012.09.014 10.1055/s-0039-1681032 10.1038/nature09968 10.1038/ncomms7794 10.1038/s41572-018-0014-7 10.1053/j.gastro.2011.09.002 10.1002/hep.24368 10.1146/annurev.med.60.042307.110802 10.1053/j.gastro.2004.09.049 10.1056/nejmra0805786 10.1038/s41467-022-35069-9 10.1016/j.cell.2008.09.059 10.3389/fimmu.2023.1184010 10.1002/hep.23382 10.1042/bj20140881 10.1038/nm.2173 10.1038/s41467-018-07287-7 10.1016/j.jhep.2010.11.005 10.1152/ajpgi.00542.2004 10.1074/jbc.m202411200 10.1073/pnas.1117792109 10.1126/science.1078197 10.1038/169800b0 10.1007/s11010-009-0142-1 |
ContentType | Journal Article |
Copyright | Copyright © 2025 Korean Diabetes Association 2025 |
Copyright_xml | – notice: Copyright © 2025 Korean Diabetes Association 2025 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA ACYCR |
DOI | 10.4093/dmj.2024.0215 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals Korean Citation Index |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2233-6087 |
EndPage | 811 |
ExternalDocumentID | oai_kci_go_kr_ARTI_10732537 oai_doaj_org_article_d39678d1df7a41928ddd6b019b96e475 PMC12270569 39905656 10_4093_dmj_2024_0215 |
Genre | Journal Article |
GroupedDBID | 5-W 5VS 7RV 7X7 88E 8FI 8FJ 8JR 8XY 9ZL AAYXX ABDBF ABUWG ADBBV AFKRA ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BENPR CCPQU CITATION DIK EF. FYUFA GROUPED_DOAJ HMCUK HYE KQ8 M1P NAPCQ O5R O5S PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PSQYO RPM UKHRP ADRAZ CGR CUY CVF ECM EIF IPNFZ M48 NPM RIG 7X8 5PM ACYCR |
ID | FETCH-LOGICAL-c3625-8ba478948b353c37741cbc99ff55ccd3c0aab36c1a3dc3499a416a57e68459fa3 |
IEDL.DBID | DOA |
ISSN | 2233-6079 2233-6087 |
IngestDate | Sun Jul 06 03:13:48 EDT 2025 Wed Aug 27 01:31:39 EDT 2025 Thu Aug 21 18:25:44 EDT 2025 Thu Sep 04 21:47:26 EDT 2025 Sun Jul 20 01:30:34 EDT 2025 Sun Aug 03 02:34:30 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Tryptophan hydroxylase Fatty liver Liver diseases Serotonin Alcoholics Receptors, serotonin Endoplasmic reticulum stress |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3625-8ba478948b353c37741cbc99ff55ccd3c0aab36c1a3dc3499a416a57e68459fa3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Inseon Hwang and Jung Eun Nam contributed equally to this study as first authors. |
ORCID | 0000-0002-7021-8406 0009-0006-5191-4525 0000-0002-6652-1349 0000-0001-6324-2224 |
OpenAccessLink | https://doaj.org/article/d39678d1df7a41928ddd6b019b96e475 |
PMID | 39905656 |
PQID | 3163504800 |
PQPubID | 23479 |
PageCount | 14 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_10732537 doaj_primary_oai_doaj_org_article_d39678d1df7a41928ddd6b019b96e475 pubmedcentral_primary_oai_pubmedcentral_nih_gov_12270569 proquest_miscellaneous_3163504800 pubmed_primary_39905656 crossref_primary_10_4093_dmj_2024_0215 |
PublicationCentury | 2000 |
PublicationDate | 2025-07-01 |
PublicationDateYYYYMMDD | 2025-07-01 |
PublicationDate_xml | – month: 07 year: 2025 text: 2025-07-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Diabetes & metabolism journal |
PublicationTitleAlternate | Diabetes Metab J |
PublicationYear | 2025 |
Publisher | Korean Diabetes Association 대한당뇨병학회 |
Publisher_xml | – name: Korean Diabetes Association – name: 대한당뇨병학회 |
References | ref13 ref35 ref12 ref34 ref15 ref37 ref14 ref36 ref31 ref30 ref11 ref33 ref10 ref32 ref2 ref1 ref17 ref39 ref16 ref38 ref19 ref18 Galli (ref8) 2001 ref24 ref23 ref26 ref25 ref20 ref42 ref41 ref22 ref44 ref21 ref43 ref28 ref27 ref29 ref7 ref9 ref4 ref3 ref6 ref5 ref40 |
References_xml | – ident: ref18 doi: 10.1111/j.1365-2982.2009.01370.x – ident: ref1 doi: 10.1016/s0140-6736(09)60746-7 – ident: ref14 doi: 10.1016/s0016-5085(03)00276-2 – ident: ref34 doi: 10.1038/s41598-018-36097-6 – ident: ref40 doi: 10.1002/hep.26419 – ident: ref39 doi: 10.1111/j.1440-1746.2007.05276.x – ident: ref13 doi: 10.1155/2012/479348 – ident: ref44 doi: 10.1016/j.tips.2018.03.004 – ident: ref27 doi: 10.1385/mn:29:1:31 – ident: ref9 doi: 10.1002/hep.23258 – ident: ref12 doi: 10.1155/2014/513787 – ident: ref2 doi: 10.1016/j.jhep.2013.03.007 – ident: ref35 doi: 10.1038/nprot.2013.032 – ident: ref32 doi: 10.1038/nm1780 – ident: ref23 doi: 10.1111/j.1463-1326.2011.01378.x – ident: ref30 doi: 10.1126/science.1123842 – ident: ref17 doi: 10.1097/01.alc.0000174691.03751.11 – ident: ref20 doi: 10.1126/science.1097540 – ident: ref33 doi: 10.1038/nm.2490 – ident: ref25 doi: 10.1016/j.cmet.2012.09.014 – start-page: 68 volume-title: The transcriptional and DNA binding activity of peroxisome proliferator-activated receptor alpha is inhibited by ethanol metabolism: a novel mechanism for the development of ethanol-induced fatty liver year: 2001 ident: ref8 – ident: ref11 doi: 10.1055/s-0039-1681032 – ident: ref16 doi: 10.1038/nature09968 – ident: ref26 doi: 10.1038/ncomms7794 – ident: ref3 doi: 10.1038/s41572-018-0014-7 – ident: ref4 doi: 10.1053/j.gastro.2011.09.002 – ident: ref42 doi: 10.1002/hep.24368 – ident: ref21 doi: 10.1146/annurev.med.60.042307.110802 – ident: ref6 doi: 10.1053/j.gastro.2004.09.049 – ident: ref10 doi: 10.1056/nejmra0805786 – ident: ref36 doi: 10.1038/s41467-022-35069-9 – ident: ref29 doi: 10.1016/j.cell.2008.09.059 – ident: ref37 doi: 10.3389/fimmu.2023.1184010 – ident: ref7 doi: 10.1002/hep.23382 – ident: ref41 doi: 10.1042/bj20140881 – ident: ref28 doi: 10.1038/nm.2173 – ident: ref31 doi: 10.1038/s41467-018-07287-7 – ident: ref43 doi: 10.1016/j.jhep.2010.11.005 – ident: ref38 doi: 10.1152/ajpgi.00542.2004 – ident: ref5 doi: 10.1074/jbc.m202411200 – ident: ref24 doi: 10.1073/pnas.1117792109 – ident: ref19 doi: 10.1126/science.1078197 – ident: ref22 doi: 10.1038/169800b0 – ident: ref15 doi: 10.1007/s11010-009-0142-1 |
SSID | ssj0000480779 |
Score | 2.3600466 |
Snippet | Background: Serotonin (5-hydroxytryptamine [5-HT]) is a monoamine neurotransmitter that has various functions in central and peripheral tissues. While 5-HT is... Serotonin (5-hydroxytryptamine [5-HT]) is a monoamine neurotransmitter that has various functions in central and peripheral tissues. While 5-HT is known to... Background Serotonin (5-hydroxytryptamine [5-HT]) is a monoamine neurotransmitter that has various functions in central and peripheral tissues. While 5-HT is... |
SourceID | nrf doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 798 |
SubjectTerms | alcoholics Animals Disease Models, Animal endoplasmic reticulum stress Endoplasmic Reticulum Stress - drug effects Endoplasmic Reticulum Stress - physiology fatty liver Female Humans Lipogenesis - drug effects Lipogenesis - physiology Liver - metabolism Liver - pathology liver diseases Liver Diseases, Alcoholic - blood Liver Diseases, Alcoholic - genetics Liver Diseases, Alcoholic - metabolism Liver Diseases, Alcoholic - pathology Male Mice Mice, Inbred C57BL Mice, Knockout Original Receptor, Serotonin, 5-HT2A - genetics Receptor, Serotonin, 5-HT2A - metabolism Receptor, Serotonin, 5-HT2B - genetics Receptor, Serotonin, 5-HT2B - metabolism receptors, serotonin serotonin Serotonin - blood Serotonin - metabolism tryptophan hydroxylase Tryptophan Hydroxylase - genetics Tryptophan Hydroxylase - metabolism 내과학 |
Title | Serotonin Regulates Lipogenesis and Endoplasmic Reticulum Stress in Alcoholic Liver Disease |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39905656 https://www.proquest.com/docview/3163504800 https://pubmed.ncbi.nlm.nih.gov/PMC12270569 https://doaj.org/article/d39678d1df7a41928ddd6b019b96e475 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003222188 |
Volume | 49 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Diabetes and Metabolism Journal, 2025, 49(4), 210, pp.798-811 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9QwDLdgSIgXxPjsxk5FIN7K2ub7cWM3DdgmGEw6iYcoTdJRprWnu9v_j5Pcpjs0iRdeWqlJWtdu7Z_jxAZ4RzkvRWsRualWFVS4ulCEmwL1cQjEiJbHqYGTU350Tj9P2GSl1FdYE5bSAyfG7TqiUJ-6yrXChIildM7xBoFJo7inImYvLVW54kxFHRx2SsdEe2j-SIH0qJRgE90ZsuuufqNnWNMPweCtGaSYtx_NTD9r74Kcf6-cXDFFh0_g8RJD5nuJ9k245_un8PBkGSV_Bj9RAQyLMM-an6VS836eH3fT4SIotm6em97l494NU4TOV53FXos0DZh_j1tHchy5l2rnYutxWLqRH6RIznM4Pxz_-HhULIsoFBZtEytkY6iQisqGMGIJor3KNlaptmXMWkdsaUxDuK0McZag_4Nc5oYJzyVlqjXkBWz0Q-9fQV4ZlINlFXeupp5I6YnFX5hXjtQG75PB-xtO6mnKlaHRxwgs18hyHViuA8sz2A98vu0UUlzHCyh4vRS8_pfgM3iLUtKXtovjw_li0JczjY7AJ3yuIDUjIoM3N1LU-OOEaIjp_XA910g4YeE7KTN4maR6SxCitjIg3QzkmrzXKF5v6btfMTl3VdcCx6qt__GO2_CoDvWG4_Lg17CxmF37HQRBi2YE98VEjODB_vj069kofv14_PJN_gG0KwX8 |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serotonin+Regulates+Lipogenesis+and+Endoplasmic+Reticulum+Stress+in+Alcoholic+Liver+Disease&rft.jtitle=Diabetes+%26+metabolism+journal&rft.au=Hwang%2C+Inseon&rft.au=Nam%2C+Jung+Eun&rft.au=Choi%2C+Wonsuk&rft.au=Choi%2C+Won+Gun&rft.date=2025-07-01&rft.pub=Korean+Diabetes+Association&rft.issn=2233-6079&rft.eissn=2233-6087&rft.volume=49&rft.issue=4&rft.spage=798&rft.epage=811&rft_id=info:doi/10.4093%2Fdmj.2024.0215&rft_id=info%3Apmid%2F39905656&rft.externalDocID=PMC12270569 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2233-6079&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2233-6079&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2233-6079&client=summon |